News | May 08, 2024
WACKER expands production capacity for biopharmaceuticals in San Diego
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Highly effective preservation solutions ensuring the safety and protection of personal care products
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Subscribe To Our Newsletter & Stay Updated
